David Sinclair· PhD
There's a company that makes it in pure from very low levels of gluten. And just the last few months I've added that to my protocol and we'll have to see how my numbers look on Inside Tracker.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
There's a company that makes it in pure from very low levels of gluten. And just the last few months I've added that to my protocol and we'll have to see how my numbers look on Inside Tracker.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Uh a gram as well.